|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$1,855
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
SWOG NCORP Research Base
|
5UG1CA189974-04
|
$4,459,372
|
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
CSHL Cancer Center Support Grant
|
5P30CA045508-30
|
$4,395,404
|
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
University of Rochester-NCORP Research Base
|
5UG1CA189961-04
|
$3,781,235
|
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
COG NCORP Research Base
|
5UG1CA189955-04
|
$3,690,706
|
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-09
|
$3,203,095
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrative analysis of lung cancer etiology and risk
|
1U19CA203654-01A1
|
$2,833,706
|
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Optimization of High Dose Conformal Therapy
|
5P01CA059827-19
|
$2,754,436
|
|
TEN HAKEN, RANDALL
|
UNIVERSITY OF MICHIGAN
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-05
|
$2,680,381
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
|
5U54CA198999-03
|
$2,636,624
|
|
HUANG, LEAF
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Molecular pathological epidemiology of colorectal cancer
|
5U01CA137088-08
|
$2,523,163
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SPORE in Prostate Cancer
|
5P50CA092629-17
|
$2,436,043
|
|
SCHER, HOWARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-03
|
$2,403,338
|
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach
|
5P01CA180945-04
|
$2,380,611
|
|
FIORE, MICHAEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
SPORE in Prostate Cancer
|
5P50CA186786-04
|
$2,380,000
|
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN
|
|
SPORE in Pancreatic Cancer
|
5P50CA127297-09
|
$2,379,383
|
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
SPORE in Skin Cancer
|
5P50CA121973-10
|
$2,350,000
|
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
SPORE in Cervical Cancer
|
5P50CA098252-14
|
$2,300,000
|
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Mayo Clinic Ovarian Cancer SPORE
|
5P50CA136393-08
|
$2,300,000
|
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
5P50CA159981-05
|
$2,300,000
|
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
|
5P50CA174521-03
|
$2,300,000
|
|
O'DORISIO, M. SUE
|
UNIVERSITY OF IOWA
|
|
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
|
5P50CA100632-15
|
$2,300,000
|
|
KANTARJIAN, HAGOP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
SPORE in Skin Cancer
|
5P50CA174523-04
|
$2,300,000
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Duke SPORE in Brain Cancer
|
5P50CA190991-04
|
$2,298,025
|
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
|
1P01CA206980-01A1
|
$2,292,665
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-03
|
$2,271,783
|
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
MSK SPORE in Lymphoma
|
5P50CA192937-02
|
$2,251,577
|
|
YOUNES, ANAS
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
|
5U01CA195568-03
|
$2,248,270
|
|
CERHAN, JAMES
|
MAYO CLINIC ROCHESTER
|
|
Cancer as a Complex Adaptive System
|
5U54CA193489-03
|
$2,240,338
|
|
GATENBY, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-03
|
$2,224,884
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
The Pacific Northwest Prostate Cancer SPORE
|
5P50CA097186-15
|
$2,220,357
|
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
SPORE in Thyroid Cancer
|
5P50CA172012-04
|
$2,136,667
|
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Johns Hopkins Physical Sciences Oncology Center
|
5U54CA210173-02
|
$2,118,358
|
|
WIRTZ, DENIS
|
JOHNS HOPKINS UNIVERSITY
|
|
MD Anderson Cancer Center Prostate Cancer SPORE
|
5P50CA140388-07
|
$2,100,013
|
|
LOGOTHETIS, CHRISTOPHER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA034196-32
|
$2,100,000
|
|
LIU, EDISON
|
JACKSON LABORATORY
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-05
|
$2,051,965
|
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-13
|
$2,039,886
|
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cellular and Molecular Studies of Bone Marrow Transplant
|
5P01CA039542-29
|
$2,037,038
|
|
FERRARA, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship
|
5U01CA195565-02
|
$2,033,770
|
|
KUSHI, LAWRENCE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
MOTILITY AND INVASION
|
5P01CA100324-15
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors
|
5U54CA210180-02
|
$2,012,210
|
|
WHITE, FOREST
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-38
|
$1,812,080
|
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Integrated EGFR function in cytokine-driven inflammation and cancer
|
5P01CA062220-22
|
$1,805,475
|
|
STARK, GEORGE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma
|
1P01CA207206-01A1
|
$1,793,324
|
|
DEBINSKI, WALDEMAR
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
5P01CA177322-04
|
$1,778,661
|
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Inflammatory Bowel Disease for this search: $1,490,892
|